Laura Rodríguez‐Pascau

Statistics

Publications

Citations

322

H-Index

Active since

2009

Affiliations

Centre for Biomedical Network Research on Rare Diseases(Current)

Universitat de Barcelona

Instituto de Investigación de Enfermedades Raras

Institut de Biomedicina de la Universitat de Barcelona

Bone Therapeutics

Laura Rodríguez‐Pascau is an author at Centre for Biomedical Network Research on Rare Diseases specializing in life sciences, pharmacology, and genetics.

ORCID

Publications per year

2009–2024

Publications

PPAR gamma agonist leriglitazone improves frataxin-loss impairments in cellular and animal models of Friedreich Ataxia

Laura Rodríguez‐Pascau, Elena Britti, Pablo Calap-Quintana et al. · Neurobiology of Disease · 2020 · 60 citations · Full text

Life Sciences, Neuroscience, Pharmacology +17

Antisense oligonucleotide treatment for a pseudoexon-generating mutation in the<i>NPC1</i>gene causing Niemann-Pick type C disease

Laura Rodríguez‐Pascau, María Josep Coll, Lluı̈sa Vilageliu et al. · Human Mutation · 2009 · 51 citations

Life Sciences, Genetics, Molecular Genetics +17

Molecular analysis of 30 Niemann-Pick type C patients from Spain

Judit Macías‐Vidal, Laura Rodríguez‐Pascau, Gessamí Sánchez-Ollé et al. · Clinical Genetics · 2010 · 46 citations

Life Sciences, Genetics, Molecular Genetics +17

Safety and efficacy of leriglitazone for preventing disease progression in men with adrenomyeloneuropathy (ADVANCE): a randomised, double-blind, multi-centre, placebo-controlled phase 2–3 trial

Wolfgang Köhler, Marc Engelen, Florian Eichler et al. · The Lancet Neurology · 2023 · 42 citations · Full text

Medicine, Endocrinology, Pharmacology +4

The brain penetrant PPARγ agonist leriglitazone restores multiple altered pathways in models of X-linked adrenoleukodystrophy

Laura Rodríguez‐Pascau, Anna Vilalta, Marc Cerrada et al. · Science Translational Medicine · 2021 · 39 citations

Life Sciences, Neuroscience, Pharmacology +11

1–5 of 9